Avoiding a blood transfusion: How much is it worth?

Crit Care Med. 2005 Mar;33(3):672-4. doi: 10.1097/01.ccm.0000159093.09084.d6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Blood Transfusion / economics
  • Blood Transfusion / mortality
  • Cost-Benefit Analysis
  • Critical Illness*
  • Erythropoietin / economics*
  • Erythropoietin / therapeutic use
  • Health Care Costs*
  • Humans
  • Morbidity*
  • Recombinant Proteins
  • Transfusion Reaction*
  • United States / epidemiology

Substances

  • Recombinant Proteins
  • Erythropoietin